Twice-Daily Fludarabine and Cytarabine Combination With or Without Gentuzumab Ozogamicin is Effective in Patients With Relapsed/Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, and Blast- Phase Chronic Myeloid Leukemia
Titel:
Twice-Daily Fludarabine and Cytarabine Combination With or Without Gentuzumab Ozogamicin is Effective in Patients With Relapsed/Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, and Blast- Phase Chronic Myeloid Leukemia
Auteur:
Jabbour, Elias Garcia-Manero, Guillermo Cortes, Jorge Ravandi, Farhad Plunkett, William Gandhi, Varsha Faderl, Stefan O'Brien, Susan Borthakur, Gautam Kadia, Tapan Burger, Jan Konopleva, Marina Brandt, Mark Huang, Xuelin Kantarjian, Hagop